Clinical trials
Recruiting Phase 2 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| University of Alabama at Birmingham | 2 |
| Chi Kong Li | 1 |
| Cogent Biosciences, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Dana-Farber Cancer Institute | 1 |
| Etan Orgel | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Hannah Choe, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 28 |
| Leukemia, Myeloid, Acute | 9 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma | 4 |
| Graft vs Host Disease | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Myeloproliferative Disorders | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hematologic Diseases | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.